The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization

Experimental Eye Research

Volumn 67, Issue 2, 1998, Pages 133-142

  Benelli, Umberto ^a   Bocci, Guido ^a   Danesi, Romano ^a   Lepri, Antonio ^a   Bernardini, Nunzia ^a   Bianchi, Francesco ^a   Lupetti, Mario ^a   Dolfi, Amelio ^a   Campagni, Antonio ^b   Agen, Cristiana ^a   Nardi, Marco ^a   Del Tacca, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CISAM Interce Ctr Studs M   (Italy)

Author keywords

Angiogenesis; bFGF; In vitro models; Rat cornea; Suleparoide

Indexed keywords

HEPARAN SULFATE; SULEPAROIDE;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CORNEA NEOVASCULARIZATION; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

EID: 0032144583     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1998.0512     Document Type: Article

References (46)

1. Adamis A. P., Meklir B., Joyce N. C. In situ injury-induced release of basic-fibroblast growth factor from corneal endothelial cells. Am. J. Pathol. 139:1991;961-966.
2. Amano S., Rohan R., Kuroki M., Tolentino M., Adamis A. P. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 39:1998;18-22.
3. American Medical Association. Ophthalmic anti-inflammatory agents, decongestants, and antiallergy agents. Drug evaluations. Annual 1995. 1995;A.M.A. p. 2263-9.
4. Ausprunk D. H, Dethlefsen S. M., Higgins E. R. Distribution of fibronectin, laminin and types IV collagen during development of blood vessels in the chick chorioallantoic membrane. Feinberg R. N, Sherer G. K., Auerbach R. The development of the vascular system. 1991;95-108 Basel.
5. Baird A., Mormede P., Bohlen P. Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggest its identity with macrophage-derived growth factor. Biochem. Biophys. Res. Commun. 126:1985;358-364.
6. Benelli U., Ross J. R., Nardi M., Klintworth G. K. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Invest. Ophthalmol. Vis. Sci. 38:1997;274-282.
7. BenEzra D., Griffin B. W., Maftzir G., Sharif N. A., Clark A. F. Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 38:1997;1954-1962.
8. Brem S. S., Zagzag D., Tsanaclis A. M. C., Gately S., Elkouby M. P., Brien S. E. Inhibition of angiogenesis and tumour growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor. Am. J. Pathol. 137:1990;1121-1128.
9. Callas D. D., Ahsan A., Iqbal O., Fareed J. Molecular weight and biochemical profile of a chemically modified heparin derivative, suleparoide. Thromb. Res. 69:1993a;369-376.
10. Callas D. D., Hoppensteadt D. A., Jeske W., Iqbal O., Bacher P., Ahsan A., Fareed J. Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, Suleparoide. Semin. Thromb. Hemost. 19 Suppl. 1:1993b;49-57.
11. Cauchi J., Alcorn D., Cancilla B., Key B., Berka J. L., Nurcombe V., Ryan G. B., Bertram J. F. Light-microscopic immunolocalization of fibroblast growth factor-1 and -2 in adult rat kidney. Cell Tissue Res. 285:1996;179-187.
12. Chiarugi V., Ruggiero M., Porciatti F., Vannucchi S., Ziche M. Cooperation of heparin with other angiogenetic effectors. Int. J. Tissue React. 8:1986;129-133.
13. Ciomei M., Pastor I. W., Mariani M., Sola F., Grandi M., Mongelli N. New sulfonated distamycin A derivatives with bFGF complexing activity. Biochem. Pharmacol. 47:1994;295-302.
14. Cockerill G. W., Gamble J. R., Vadas M. A. Angiogenesis: models and modulators. Int. Rev. Cytol. 159:1995;113-160.
15. Crum R., Szabo S., Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science. 230:1985;1375-1378.
16. Culton M., Chandler D. B., Proia A. D., Hickingbotham D., Klintworth G. K. The effect of oxygen on corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 31:1990;1277-1281.
17. Danesi R., Del Bianchi S., Soldani P., Campagni A., La Rocca R. V., Myers C. E., Paparelli A., Del Tacca M. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane. Br. J. Cancer. 68:1993;932-938.
18. Danesi R., Agen C., Benelli U., Di Paolo A., Nardini D., Bocci G., Basolo F., Campagni A., Del Tacca M. Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995). Clin. Cancer Res. 3:1997;265-272.
19. Diglio C. A., Grammas P., Giacomelli F., Wiener J. Angiogenesis in rat aorta ring explant cultures. Lab. Invest. 60:1989;523-531.
20. Epstein R. J., Stulting R. D., Hendricks R. L., Harris D. M. Corneal neovascularization: pathogenesis and inhibition. Cornea. 6:1987;250-258.
21. Folkman J., Langer R., Linhardt R. J., Haudenschild C., Taylor S. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science. 221:1983;719-725.
22. Hahnenberger R., Jakobson A. M. Antiangiogenic effect of sulphated and nonsulphated glycosaminoglycans and polysaccharides in the chick embryo chorioallantoic membrane. Glycoconj. J. 8:1991;350-353.
23. Hill J. C., Maske R. An animal model for corneal graft rejection in high-risk keratoplasty. Transplantation. 46:1988;26-30.
24. Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Brem H., Folkman J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature. 348:1990;555-557.
25. Ingber D., Madri J. A., Folkman J. A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. Endocrinology. 119:1986;1768-1775.
26. Kalebic T., Garbisa S., Glaser B., Liotta L. A. Basement membrane collagen: degradation by migrating endothelial cells. Science. 221:1983;281-284.
27. Kenyon B. M., Browne F., D'Amato R. J. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp. Eye Res. 64:1997;971-978.
28. Koch A. E., Polverini P. J., Kunkel S. L., Harlow L. A., Di Pietro L. A., Elner V. M., Elner S. G., Strieter R. M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 258:1992;1798-1801.
29. Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wisemann, D. M., Shively, V. and Nuseir, N. (1987). Macrophage-induced angiogenesis is mediated by tumor necrosis factor-α. Nature 329, 630-2.
30. Lepri A., Benelli U., Chetoni P., Perini G., Saettone M. F., Nardi M. Effect of suleparoide on fibrinolysis in the anterior chamber of rabbits. Ophthalmic Res. 28:1996;176-183.
31. Lipman R. M., Epstein R. J., Hendricks R. L. Suppression of corneal neovascularization with cyclosporine. Arch. Ophthalmol. 110:1992;405-407.
32. Murata J., Saiki I., Makabe T., Tsuta Y., Tokura S., Azuma I. Inhibition of tumor-induced angiogenesis by sulfated chitin derivatives. Cancer Res. 51:1991;22-26.
33. Murata M., Nakagawa M., Takahashi S. Inhibitory effects of plasminogen fragment on experimentally induced neovascularization of rat corneas. Graefes Arch. Clin. Exp. Ophthalmol. 235:1997;584-589.
34. Proia A. D., Chandler D. B., Haynes W. L., Smith C. F., Suvarnamani C., Erkel F. H., Klintworth G. Quantitation of corneal neovascularization using computerized image analysis. Lab. Invest. 58:1988;473-479.
35. Ribatti D., Urbinati C., Nico B., Rusnati M., Roncali L., Presta M. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev. Biol. 170:1995;39-49.
36. Rifkin D. B., Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109:1989;1-6.
37. Risau W. Angiogenic growth factors. Prog. Growth Factor Res. 2:1990;71-79.
38. Ruoslahti E., Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 64:1991;867-869.
39. Saksela O., Moscatelli D., Sommer A., Rifkin D. B. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 107:1988;743-751.
40. Scroggs M. W., Proia A. D., Smith C. F., Halperin E. C., Klintworth G. K. The effect of total-body irradiation on corneal neovascularization in the Fischer 344 rat after chemical cauterization. Invest. Ophthalmol. Vis. Sci. 32:1991;2105-2111.
41. Soubrane G., Jerdan J., Karpouzas I., Fayein N. A., Glaser B., Coscas G., Courtois Y., Jeanny J. C. Binding of basic fibroblast growth factor to normal and neovascularized rabbit cornea. Invest. Ophthalmol. Vis. Sci. 31:1990;323-333.
42. Sunderkotter C., Roth J., Sorg C. Immunohistochemical detection of bFGF and TNF-α in the course of inflammatory angiogenesis in the mouse cornea. Am. J. Pathol. 137:1990;511-515.
43. Tanaka N. G., Sakamoto N., Korenaga H., Inoue K., Ogawa H., Osada Y. The combination of a bacterial polysaccharide and tamoxifen inhibits angiogenesis and tumour growth. Int. J. Radiat. Biol. 60:1991;79-83.
44. Wooste P., Brightwell J., Eiferman R., Schultz G. Effects of growth factors with dexamethasone on healing of corneal stromal incision. Exp. Eye Res. 40:1985;47-60.
45. Yayon A., Klagsbrun M., Esko J. D., Leder P., Ornitz D. M. Cell surface heparin like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 64:1991;841-848.
46. 1. J. Natl. Cancer Inst. 69:1982;475-480.